Churg–Strauss syndrome: still a clinical challenge

References

• Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am. J. Pathol.27, 277–301 (1951).
   PubMed Web of Science ®Google Scholar
• Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine63, 65–81 (1984).
   PubMed Web of Science ®Google Scholar
• Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum.33, 1094–1100 (1990).
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum.37, 187–192 (1994).
   PubMed Web of Science ®Google Scholar
• Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann. Rheum. Dis.66, 222–227 (2007).
   PubMed Web of Science ®Google Scholar
• Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N. Engl. J. Med.299, 926–930 (1978).
   PubMed Web of Science ®Google Scholar
• Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndrome. Arthritis Rheum.52, 2926–2935 (2005).
   PubMed Web of Science ®Google Scholar
• Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID) J. Allergy Clin. Immunol.113, 11–28 (2004).
   PubMed Web of Science ®Google Scholar
• Rolla G, Tartaglia N, Motta M et al. Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg–Strauss syndrome. Ann. Allergy Asthma Immunol.98, 595–597 (2007).
   PubMedGoogle Scholar
• Ramakrishna G, Midthun DE. Churg–Strauss syndrome. Ann. Allergy Asthma Immunol.86, 603–613 (2001).
   PubMedGoogle Scholar
• Rolla G, Heffler E, Guida G et al. Exhaled nitric oxide in diffuse alveolar haemorrhage. Thorax60, 614–615 (2005).
   PubMedGoogle Scholar
• Mitsuyama H, Matsuyama W, Watanabe M et al. Increased expression of TRAIL receptor 3 on eosinophils in Churg–Strauss syndrome. Arthritis Rheum.56, 672–683 (2007).
   Google Scholar
• Mitsuyama H, Matsuyama W, Iwakawa J et al. Increased serum vascular endothelial growth factor level in Churg–Strauss syndrome. Chest129, 407–411 (2006).
   PubMedGoogle Scholar
• Taira T, Matsuyama W, Mitsuyama H et al. Increased serum high mobility group box-1 level in Churg–Strauss syndrome. Clin. Exp. Immunol.148, 241–247 (2007).
   PubMed Web of Science ®Google Scholar
• Schmitt WH, Csernok E, Kobayashi S et al. Churg–Strauss syndrome : serum markers of of lymphocytic activation and endpothelial damage. Arthritis Rheum.41, 4445–4452 (1998).
   Google Scholar
• Müschen M, Warskulat U, Perniok A et al. Involvement of soluble CD95 in Churg–Strauss syndrome. Am. J. Pathol.155, 915–925 (1999).
   PubMed Web of Science ®Google Scholar
• Chen R, Sakamoto M, Ikemoto K, Abe R, Shimizu H. Granulomatous arteritis in cutaneous lesions of Churg–Strauss syndrome. J. Cutan. Pathol.34, 330–337 (2007).
   PubMed Web of Science ®Google Scholar
• Hattori N, Ichimura N, Nagamatsu M et al. Clinicopathological features of Churg–Strauss syndrome-associated neuropathy. Brain122, 427–439 (1999).
   PubMed Web of Science ®Google Scholar
• Kiene M, Csernok E, Muller A, Metzler C, Trabandt A, Gross WL. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg–Strauss syndrome. Arthritis Rheum.44, 469–473 (2001).
   PubMed Web of Science ®Google Scholar
• Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin. Exp. Immunol.103, 253 (1996).
   PubMed Web of Science ®Google Scholar
• Serna-Candel C, Moreno-Perez O, Soriano V, Martinez A. Churg–Strauss syndrome triggered by hyposensitization to Alternaria fungus. Clin. Rheumatol. (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary systemic vasculitis? A case-control study, Arthritis Rheum.48, 814–823 (2003).
   PubMed Web of Science ®Google Scholar
• Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr. Opin. Rheumatol.11, 24–33 (1999).
   PubMedGoogle Scholar
• Guida G, Heffler E, Cignetti A et al. T cell Vβ clonal expansion with a Th1 phenotype in Churg Strass sindrome. Prestented at: XXV Congress of the European Academy of Allergology and Clinical Immunology. Vienna, Austria, 10–14 June 2006 (Abstract 317).
   Google Scholar
• Direskeneli H, Eksioglu-Demiralp E, Kibaroglu A et al. Oligoclonal T cell expansions in patients with Behcet’s disease. Clin. Exp. Immunol.117, 166–170 (1999).
   PubMed Web of Science ®Google Scholar
• Mayo MJ, Jenkins RN, Combes B et al. Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma. Hepatology29, 1635–1642 (1999).
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol. Rev.211, 214–224 (2006).
   PubMed Web of Science ®Google Scholar
• Lamprecht P, Csernok E, Gross WL. Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener’s granulomatosis. J. Intern. Med.260, 187–191 (2006).
   PubMed Web of Science ®Google Scholar